Medical devices, healthcare technology and the business of care
PMA approval · P220031

LimiFlex Dynamic Sagittal Tether

Empirical Spine, Inc. · Decision date Feb 12, 2026

FDA DECISIONP220031

What did the FDA approve?

FDA records P220031 as an original PMA application. The recorded decision is approval, dated Feb 12, 2026.

FDA approval order statement

undefined
Regulatory pathway
Original PMA
Clinical specialty
Orthopedic
Decision date
Feb 12, 2026

FDA source record

Regulatory record facts

Identifier
P220031
Regulatory pathway
Premarket approval application
Product code
SGK
Decision code
APPR
Decision date
Feb 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, spinous process tension band implant.

Product code
SGK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P220031 received

    Application receipt date recorded by FDA.

  2. P220031 · FDA decision

    APPR

  3. P220031/S001 · Related supplement

    LimiFlex Dynamic Sagittal Tether

Timeline entries are records held by MedtechLedger for P220031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220031

Product / regulatory recordCompanyPathwayDecision dateSource
Empirical Spine, Inc.PMA supplementApr 8, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Empirical Spine, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
18655 Madrone Pkwy., Suite 180, Morgan Hill, CA, 95037

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records